Mathilde Léonard

Dr. Mathilde Léonard


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Alexandru OanceaAlexandru Oancea
Alexandru Oancea
MLMathilde Léonard
Mathilde Léonard
GBGina Eosefina Botnariu
Gina Eosefina Botnariu
Ionela-Larisa MiftodeIonela-Larisa Miftode
Ionela-Larisa Miftode
Alexandru BurlacuAlexandru Burlacu
Alexandru Burlacu
Mariana FloriaMariana Floria
Mariana Floria
Hepatocellular carcinoma (HCC) develops through cooperation between altered hepatocytes, chronic liver injury and a stromal and immune environment. Genomic alterations and signaling abnormalities provide a rationale for treatment development, but pathway activation rarely identifies therapeutic dependence alone. This narrative review connects hepatic stellate-cell states, tumor-cell plasticity, genomic instability and four major signaling pathways with antigen presentation, immune exclusion and clinical treatment evidence. Targeted searches were updated through 6 October 2026, retaining foundational work and prioritizing recent studies. Single-cell and spatial analyses reveal that stellate cells and cancer-associated fibroblasts can exert opposing effects according to their state and location. Similarly, CTNNB1-associated signaling can favor immune exclusion, but mutation status does not fully capture immune context or establish universal resistance to checkpoint combinations. Intratumoral dendritic-cell and lymphocyte organization, suppressive myeloid niches and humoral responses provide complementary explanations of treatment heterogeneity. Randomized trials support selected antiangiogenic and checkpoint combinations in unresectable HCC, while negative trials and updated adjuvant results demonstrate the limits of extrapolating biological rationale across regimens and disease stages. The synthesis distinguishes experimental causality, patient-level association and clinically validated benefit. Translation requires compartment-specific target assessment, representative sampling and prospective biomarker evaluation within a defined treatment setting, alongside assessment of liver reserve.

3 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Alexandru OanceaAlexandru Oancea
Alexandru Oancea
MLMathilde Léonard
Mathilde Léonard
PMPaula Cristina Morariu
Paula Cristina Morariu
MGMaria Mihaela Godun
Maria Mihaela Godun
JAJigoranu Raul Alexandru
Jigoranu Raul Alexandru
Mariana FloriaMariana Floria
Mariana Floria
Atrial fibrillation frequently coexists with chronic coronary syndrome, sharing common cardiovascular risk factors and pathophysiological mechanisms. Identifying patients with chronic coronary syndrome at increased likelihood of atrial fibrillation remains clinically relevant, particularly in the absence of overt arrhythmia. Clinical and angiographic risk scores routinely used in coronary artery disease may capture cumulative cardiovascular and structural burden and could therefore assist in atrial fibrillation risk stratification. The ABC score provides a more accurate and individualized assessment of risk than traditional clinical scores in patients with AF. Materials and Methods: This prospective, single-center, proof-of-concept study included 131 consecutive patients undergoing invasive coronary angiography for suspected coronary ischemia were enrolled. Patients with and without atrial fibrillation were included, irrespective of arrhythmia subtype. Coronary artery disease severity was assessed using the Gensini and SYNTAX (PCI and CABG) scores. Global cardiovascular risk was evaluated using established clinical scores, including Framingham, ASCVD, SCORE2, and SCORE2-OP. Comparisons were performed between patients in sinus rhythm and those with different atrial fibrillation phenotypes. Correlation analyses, receiver operating characteristic curves, and multivariate logistic regression were applied to evaluate the association between risk scores, coronary disease severity, and atrial fibrillation. Results: Clinical and angiographic risk scores differed significantly according to rhythm status and atrial fibrillation subtype. Patients with atrial fibrillation exhibited higher values of global cardiovascular risk scores and greater coronary anatomical complexity compared with patients in sinus rhythm. The ABC score demonstrated the strongest discriminative performance for atrial fibrillation detection (AUC 0.908), followed by SYNTAX PCI and SYNTAX CABG. In multivariate analysis, the ABC score and SYNTAX CABG emerged as independent predictors of atrial fibrillation. Significant correlations were observed between traditional cardiovascular risk scores and SYNTAX-derived measures of coronary complexity, whereas correlations with the Gensini score were weaker. Established clinical and angiographic risk scores used in chronic coronary syndrome are associated with the presence and phenotype of atrial fibrillation. These findings support the potential role of routinely available risk scores as practical tools for identifying chronic coronary syndrome patients at increased likelihood of atrial fibrillation, facilitating targeted rhythm screening and early risk stratification.

24 March 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
Alexandru OanceaAlexandru Oancea
Alexandru Oancea
MLMathilde Léonard
Mathilde Léonard
PMPaula Cristina Morariu
Paula Cristina Morariu
MGMaria Mihaela Godun
Maria Mihaela Godun
JAJigoranu Raul Alexandru
Jigoranu Raul Alexandru
Mariana FloriaMariana Floria
Mariana Floria
Atrial fibrillation (AF) frequently coexists with chronic coronary syndrome (CCS), reflecting shared cardiovascular risk factors and structural remodeling pathways. Identifying CCS patients at increased likelihood of AF remains clinically relevant, particularly when arrhythmia is silent or paroxysmal. Background: We hypothesized that established clinical and angiographic risk scores used in CCS may capture cumulative cardiovascular burden and could therefore assist in AF risk stratification. The biomarker-based ABC-stroke score was incorporated as a biological reference framework reflecting myocardial stress and injury. Methods: This prospective, single-center proof-of-concept study included 131 consecutive patients undergoing invasive coronary angiography for suspected myocardial ischemia. Patients were classified according to rhythm status, irrespective of AF subtype. Coronary artery disease severity was quantified using the Gensini and SYNTAX (PCI and CABG) scores. Global cardiovascular risk was assessed using Framingham, ASCVD, SCORE2, and SCORE2-OP. Correlation analyses, ROC curves, and multivariable logistic regression were performed to evaluate associations between risk scores, coronary complexity, and AF. Results: Clinical and angiographic risk scores differed significantly according to rhythm status and AF phenotype. Patients with AF exhibited higher global cardiovascular risk and greater coronary anatomical complexity compared with those in sinus rhythm. SYNTAX PCI and SYNTAX CABG demonstrated moderate discriminative performance for AF detection (AUC 0.745 and 0.760, respectively), with SYNTAX CABG remaining independently associated with AF in multivariable analysis. Significant correlations were observed between traditional cardiovascular risk scores and SYNTAX-derived measures of coronary complexity, whereas correlations with the Gensini score were weaker. The ABC-stroke reference model showed a strong discriminative signal, consistent with its biological proximity to AF-related myocardial stress. Conclusions: Established clinical and angiographic risk scores used in CCS are associated with the presence and phenotype of AF. These findings suggest that routinely available coronary risk assessment tools may serve as practical instruments for identifying CCS patients at increased likelihood of AF, potentially facilitating targeted rhythm screening and earlier risk stratification.